Publications by authors named "Filip Hruby"

Claim this Profile
I
Insulin therapy DE-intensificAtion with iGlarLixi: A phase 4, open-label, parallel-group randomised controlled trial.
Peter Novodvorský, Lenka Thieme, Ivana Laňková, Štěpánka Franková, Alica Veselá

Diabetes Obes Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of screening asymptomatic patients admitted to healthcare facilities during the COVID-19 pandemic.
Petr Smejkal, Filip Hrubý, Anna Horňáková

Cent Eur J Public Health· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuated neutralization, maintained specificity: Humoral response to SARS-CoV-2 booster in kidney allograft recipients.
Martina Fialova, Eva Cecrdlova, Ivan Zahradka, Vojtech Petr, Filip Hruby

Diagn Microbiol Infect Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early referring saved lives in kidney transplant recipients with COVID-19: a beneficial role of telemedicine.
Ivan Zahradka, Vojtech Petr, Katarina Jakubov, Istvan Modos, Filip Hruby

Front Med (Lausanne)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis